Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)
This study has been completed.
Study NCT00729651 Information provided by Merck Sharp & Dohme Corp.
First Received on August 5, 2008. Last Updated on August 11, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Bone Diseases, Metabolic
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Bone Density Conservation Agents
Physiological Effects of Drugs
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers